SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001756770-24-000033
Filing Date
2024-05-10
Accepted
2024-05-09 18:17:05
Documents
7
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K q1246-kcover.htm 6-K 19167
2 EX-99.1 q124-exx992xfsandmda.htm EX-99.1 1949390
3 EX-99.2 q124ceocertification.htm EX-99.2 13127
4 EX-99.3 q124cfocertification.htm EX-99.3 12023
5 EX-99.4 q124earningsrelease.htm EX-99.4 163661
6 image_0a.jpg GRAPHIC 8736
7 curlf-20221231xex99d2001.jpg GRAPHIC 13984
  Complete submission text file 0001756770-24-000033.txt   2190044
Mailing Address 420 LEXINGTON AVENUE NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE NEW YORK NY 10170 781-451-0117
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 24932283
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)